Novel Use of Fostemsavir for 2 Multidrug-Resistant Persons With Human Immunodeficiency Virus

Ann Pharmacother. 2022 Apr;56(4):501-502. doi: 10.1177/10600280211035510. Epub 2021 Jul 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • HIV
  • HIV Infections* / drug therapy
  • Humans
  • Organophosphates
  • Piperazines
  • Tuberculosis, Multidrug-Resistant*

Substances

  • Organophosphates
  • Piperazines
  • fostemsavir